Therefore, we usually detect the expression level of p53 protein (mutant-type) using immunohistochemistry (IHC) in clinical diagnosis, but in ESCC, the positive rate of p53 protein expression varies greatly in different reports, ranging from 27 to 75% [15]. This evidence concerns the gene TP53 and esophageal squamous cell carcinoma.